- Home
- Mathematics
- Probability & Statistics
- Design and Analysis of Clinical Trials with Time-to-Event Endpoints
Design and Analysis of Clinical Trials with Time-to-Event Endpoints
List Price:
$87.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Karl E. Peace
Format:
Paperback
Pages:
616
Publisher:
CRC Press (September 10, 2018)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9781138372665
Weight:
16oz
Dimensions:
6.125" x 9.1875"
File:
TAYLORFRANCIS-TayFran_260403050835162-20260403.xml
Folder:
TAYLORFRANCIS
List Price:
$87.99
Country of Origin:
United States
Pub Discount:
30
Series:
Chapman & Hall/CRC Biostatistics Series
Case Pack:
1
As low as:
$83.59
Publisher Identifier:
P-CRC
Discount Code:
H
Imprint:
Chapman and Hall/CRC
Overview
This resource provides a thorough presentation of the design, monitoring, analysis, and interpretation of clinical trials in which time-to-event is of critical interest. Incorporating the collaborations of truly world-class statisticians, it discusses the design and monitoring of Phase II and III clinical trials with time-to-event endpoints. The book presents parametric, semiparametric, categorical, and Bayesian inferential and descriptive methods for analyzing time-to-event endpoints and covers numerous clinical trial applications, including analgesic, antibiotic, antiviral, cancer and cardiovascular prevention, optimal assignment of treatments, adverse events, and carcinogenicity.
